相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis
Wei-min Zhu et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
Carbapenem-Sparing Strategies for ESBL Producers: When and How
Ilias Karaiskos et al.
ANTIBIOTICS-BASEL (2020)
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis
Mark L. Vickers et al.
ANZ JOURNAL OF SURGERY (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Alessandro Cassini et al.
LANCET INFECTIOUS DISEASES (2019)
Treatment of Infections Due to MDR Gram-Negative Bacteria
Matteo Bassetti et al.
FRONTIERS IN MEDICINE (2019)
Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
Zhe Wang et al.
CHINESE MEDICAL JOURNAL (2018)
Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis
Cheryl Li Ling Lim et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Gowri Raman et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Carbapenemase-Producing Organisms: A Global Scourge
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2018)
Sparing carbapenem usage
A. Peter R. Wilson
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)
K. E. Goodman et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Molecular mechanisms of membrane impermeability in clinical isolates of Enterobacteriaceae exposed to imipenem selective pressure
Monica Pavez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
Yaakov Dickstein et al.
BMJ OPEN (2016)
The emerging problems of Klebsiella pneumoniae infections: carbapenem resistance and biofilm formation
Pooi Yin Chung
FEMS MICROBIOLOGY LETTERS (2016)
Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Serious Threat in ICUs
Yeşim Taşova
MEDICAL SCIENCE MONITOR (2015)
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
Pierluigi Viale et al.
INFECTIOUS DISEASES AND THERAPY (2015)
Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure
G. Meletis et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Emergence of carbapenem-resistant Klebsiella spp. infections in a Turkish university hospital: epidemiology and risk factors
Murat Dizbay et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2014)
Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance
Vered Schechner et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors
Murat Dizbay et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation
Koichi Tanimoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Christian G. Giske et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature
M. E. Falagas et al.
JOURNAL OF HOSPITAL INFECTION (2006)
The case-case-control study design: Addressing the limitations of risk factor studies for antimicrobial resistance
KS Kaye et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Clonal diversity and metallo-β-lactamase production in clinical isolates of Stenotrophomonas maltophilia
PS Mercuri et al.
MICROBIAL DRUG RESISTANCE (2002)
Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review
AD Harris et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
